Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | AGXT | P21549 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.53 |
| ▸ | DRD3 | P35462 | 2/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12668171 | 1.00 | TDP1 (0.66) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL29550888 | 1.00 | TDP1 (0.66) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL12354082 | 0.90 | TDP1 (0.68) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL8565990 | 0.87 | TDP1 (0.76) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL1859481 | 0.87 | TDP1 (0.76) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL29429997 | 0.87 | TDP1 (0.76) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL16902857 | 0.85 | TDP1 (0.73) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL16902871 | 0.85 | TDP1 (0.73) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL16902870 | 0.85 | TDP1 (0.73) | TDP1KDM4EMAPK1AGXTNPC1 | |
| SCHEMBL16902859 | 0.85 | TDP1 (0.73) | TDP1KDM4EMAPK1AGXTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022038631-A1 | QUATERNARY AMMONIUM FLUORIDE SALTS FOR FLUORINATION REACTIONS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-02-24 | — | — | WO | disclosed |
| US-20200407360-A1 | Process for Producing Fluorinated Compounds Using Alcohol Solvent Having Unsaturated Hydrocarbon | FUTURECHEM CO., LTD (KR) | 2020-12-31 | — | — | US | disclosed |
| EP-1824805-B1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO LTD (KR) | 2020-02-12 | — | — | EP | disclosed |
| EP-1824805-B1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO LTD (KR) | 2020-02-12 | — | — | EP | disclosed |
| US-9751844-B2 | Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof | FUTURECHEM CO., LTD. (KR) | 2017-09-05 | — | — | US | disclosed |
| US-20140011961-A1 | PRECURSOR COMPOUND CONNECTED TO SOLID SUPPORT FOR MANUFACTURING 18F RADIOPHARMACEUTICAL, METHOD FOR MANUFACTURING SAME, AND APPLICATION THEREOF | FUTURECHEM CO., LTD. (KR) | 2014-01-09 | — | — | US | disclosed |
| WO-2012033374-A2 | SULPHONATE PRECURSOR HAVING A 1,2,3-TRIAZOLIUM SALT, A PRODUCTION METHOD THEREFOR AND AN INTRAMOLECULAR NUCLEOPHILIC FLUORINATION REACTION USING THE SAME | 서강대학교 산학협력단 (KR) | 2012-03-15 | — | — | WO | disclosed |
| US-20110112293-A1 | Purification Strategy for Direct Nucleophilic Procedures | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-05-12 | — | — | US | disclosed |
| US-7847092-B2 | Method for preparation of F-18 containing organofluoro compounds in alcohol solvents | FUTURECHEM CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-7847092-B2 | Method for preparation of F-18 containing organofluoro compounds in alcohol solvents | FUTURECHEM CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20100113763-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO., LTD. (KR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113763-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO., LTD. (KR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113763-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO., LTD. (KR) | 2010-05-06 | — | — | US | disclosed |
| WO-2009127372-A1 | PURIFICATION STRATEGY FOR DIRECT NUCLEOPHILIC PROCEDURES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-10-22 | — | — | WO | disclosed |
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | FUTURECHEM CO., LTD. (KR) | 2008-07-17 | — | — | US | disclosed |
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | FUTURECHEM CO., LTD. (KR) | 2008-07-17 | — | — | US | disclosed |
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | FUTURECHEM CO., LTD. (KR) | 2008-07-17 | — | — | US | disclosed |
| EP-1824805-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | Futurechem Co., Ltd. (KR) | 2007-08-29 | — | — | EP | disclosed |
| WO-2006065038-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO., LTD. (KR) | 2006-06-22 | — | — | WO | disclosed |
| WO-2003076366-A2 | A METHOD FOR PREPARING ORGANIC FLUOROCOMPOUNDS | CHEMTECH RESEARCH INCORPORATION (KR) | 2003-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407360-A1 | Process for Producing Fluorinated Compounds Using Alcohol Solvent Having Unsaturated Hydrocarbon | FASN, CYP2F1, FDFT1 | TDP1 2600/4885KDM4E 3974/4885MAPK1 1383/4885 |
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | ADH5, ADH1C, ADH1A | TDP1 2689/4885KDM4E 2630/4885MAPK1 2331/4885 |
| US-20140011961-A1 | PRECURSOR COMPOUND CONNECTED TO SOLID SUPPORT FOR MANUFACTURING 18F RADIOPHARMACEUTICAL, METHOD FOR MANUFACTURING SAME, AND APPLICATION THEREOF | PFAS, RFT1, AFF1 | TDP1 1603/4885KDM4E 2235/4885MAPK1 599/4885 |
| US-20100113763-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | AFF1, AFF4, PFAS | TDP1 2415/4885KDM4E 1931/4885MAPK1 1832/4885 |
| US-20110112293-A1 | Purification Strategy for Direct Nucleophilic Procedures | MLX, SRM, STS | TDP1 2209/4885KDM4E 269/4885MAPK1 4302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.